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ABSTRACT
The purpose of this study is to survey self-reported health symptoms and knowledge of Sickle
Cell Trait in young adults with an African heritage. The aim is to expand a comprehensive
assessment system to measure factors associated with carrying the Sickle Cell Trait. Historically
being a Sickle Cell Trait carrier was thought to be asymptomatic. However, current research has
suggested this may not be true. While young adults may have greater knowledge of Sickle Cell
Disease, little is known about their awareness of Sickle Cell Trait. Furthermore, no research on
these topics have been conducted in young adults with African heritage (Latino/Hispanic,
Caribbean, Multi-Racial, etc.). Measures of Sickle Cell Trait Carrier Awareness, Sickle Cell
Trait Knowledge, and Physical Health Symptoms are presented from 54 young adults with
African Heritage. The Hispanic and Multi-Racial participants reported lower awareness of their
Sickle Cell Trait Carrier status compared to the African American participants. Hispanic and
Multi-Racial participants reported lower Sickle Cell Trait Knowledge compared to the African
American participants. All subjects demonstrated lower levels of Sickle Cell Trait Knowledge
than would be expected given the potential health consequences.
Key words: Sickle Cell Trait, Sickle Cell Trait Knowledge, College Students, Multi-Racial
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INTRODUCTION
Sickle cell disease (SCD) affects millions of people throughout the world. Approximately
70,000 to 100,000 Americans have sickle cell disease, the most common form of an inherited
blood disorder. Sickle cell disease is present in individuals at birth. It describes a group of
disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen
throughout the body (National Institutes of Health, 2012). Individuals with this SCD have
atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a
sickle, or crescent, shape (National Institutes of Health, 2012) According to the Center for
Disease Control and Prevention, it is inherited when a child receives two sickle cell genes—one
from each parent, found on chromosome 11. Individuals who inherit one sickle cell gene and one
normal gene have sickle cell trait (SCT). Historically it was thought that individuals with SCT do
not have any symptoms of SCD, but they can pass the trait on to their children (Centers for
Disease Control and Prevention, 2014).
Epidemiology of Sickle Cell Trait
Sickle cell trait affects 1 million to 3 million Americans. The sickle cell gene is most
often found in African Americans; however, it also occurs in Hispanics, South Asians,
Caucasians from southern Europe, and people from Middle Eastern countries. More than 100
million people worldwide have sickle cell trait (American Society of Hematology, 2018). The
knowledge and awareness of carrier status is important because there are risks of having a child
with sickle cell disease or a child who is a carrier. If both parents have SCT, there is a 50%
chance that any child they produce also will have SCT. Such children will not have symptoms
1

commonly associated with SCD, but they can pass SCT on to their children. If both parents have
SCT, there is a 25% chance that their child will have SCD. There is the same 25% chance that
the child will not have SCD or SCT (Centers for Disease Control and Prevention, 2014).
According to World Health Organization estimates, 5% of the global population carries the SCT.
Eight to ten percent of African Americans are affected by SCT (American Society of
Hematology, 2018).
Complications of Sickle Cell Trait
Historically SCT was not thought to have associated symptoms or complications.
However, several complications associated with SCT have been recently identified. Specifically,
associations of SCT have been found with renal disorders, muscle disorders, and sudden death
syndrome. These include renal medullary cancer, hematuria (blood in the urine), renal papillary
necrosis, hypothesnuria (reduced ability to concentrate urine), splenic infarction, exertional
rhabdomyolysis (explosive muscle breakdown), and exercise-related sudden death (Tsaras,
Owusu-Ansah, Boateng, & Amoateng-Adjepong, 2009).
Renal Dysfunction
Renal dysfunction is one of the most common complications associated with SCT. There
are two different types of Renal disorders related to SCT. Renal medullary carcinoma is a rare,
aggressive tumor of the kidney that is seen almost exclusively in young individuals with sickle
cell trait (Tsaras et al., 2009). Renal medullary carcinoma grows rapidly in an infiltrative pattern
and invades the renal sinuses, with nearly all patients dying of the disease within several months
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after diagnosis (Watanabe, Billis, Guimarães, Alvarenga, de Matos, Cardinalli, & Suzigan,
2007).
Renal medullary tumor commonly affects the right kidney, and it tends to be lobulated,
firm and poorly circumscribed (Watanabe et al., 2007). Also, another form of renal disease that is
associated with SCT is renal papillary necrosis. Renal papillary necrosis presents with painless
gross hematuria. The left kidney is more frequently involved primarily because of its larger size
and the higher venous pressure from the compression of the left renal vein on the iliac crest
between the aorta and the superior mesenteric artery (Tsaras et al., 2009). The hematuria
associated with renal papillary necrosis is commonly managed conservatively with bed rest,
intravenous hydration, and alkalization of the urine (McInnes, 1980). Renal dysfunction is
commonly found in patients with SCT. In 2009 approximately 120 cases had been reported in
total concerning the disease. Out of 120 only 1 patient was not positive for sickling status. Also,
renal medullary is a male dominant disease for men under 24. But have equal frequency by
gender after age 24 years (Tsaras et al., 2009). The origin of Renal medullary carcinoma is not
quite understood. However, experience with radiographic and pathologic findings suggests that
renal medullary carcinoma probably originates in the calyceal epithelium in or near the renal
papillae, which could be the result of the chronic ischemic damage of the epithelium of the renal
papillae related to sickled erythrocytes (Watanabe et al., 2007).
Splenic Infarcts
Splenic infarcts are an uncommon complication of sickle cell trait. Splenic infarcts can be
caused by the environmental factors such as exposure to low oxygen tension at high altitudes,
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including flight in unpressurized aircraft cabins or exercise in mountainous areas in those not
acclimatized to such areas circumscribed (Tsaras et al., 2009). The presenting symptom is left
upper-quadrant abdominal pain. Most cases of splenic infarction can be adequately treated with
lowering altitude, sufficient hydration, and analgesia, although splenectomy may be needed in
severe instances (Benenson et al., 2018). Splenic infarcts most likely affects men, non-black,
patients with greater than 40% HBS at the time of incidence, and lowlanders who ascend to high
altitude compared with native highlanders. In a previous study done in Colorado features 25
cases of splenic infarcts associated with SCT. All the male participants were symptomatic in the
first 24 hours, on ascent to altitude higher than 2300 m (7500 ft). The results suggest a high
likelihood for splenic syndrome in men of any ethnicity with left upper quadrant pain after
exposure to moderate to high altitudes. The origin of Splenic infarct occurs due to sequestration
of red cells resulting in an enlarged spleen, followed by splenic infarction caused by vasoocclusion due to sickle cells. (Yanamandra Das, Malhotra, & Varma, 2018).
Sudden Death Syndrome
Exercise-related deaths, although rare, occur at higher rates in individuals with sickle cell
trait (Tsaras et al., 2009). This is also known as sudden death syndrome and is sometimes termed
exertional rhabdomyolysis (explosive muscle breakdown). This complication has been reported
in military recruits and elite athletes when hypoxia within anaerobic skeletal muscles leads to
massive sickling, multi-organ damage, and death (Benenson et al., 2018). Most of the cases of
sudden exertional death (SED) in those with SCT have occurred during military basic training
(Murray, & Evans, 1996). SCT affects an estimated 7–9% of non-Hispanic Blacks, 0.5% of
Hispanics, to 0.2% of Whites in the U.S. general population versus 5.02% of non-Hispanic
4

Blacks, 1.08% of Hispanics, and 0.1% of Whites in the U.S. military (Singer, Chen, Shao,
Goldsmith, Byrne, & Niebuhr, 2018). In recent years, there has been heightened attention on
cases of athletes with sickle cell trait who have experienced exertion-related illness and, in some
cases, sudden death, during or after strenuous athletic training sessions (American Society of
Hematology, 2018).
Sickle Cell Knowledge
Sickle cell disease and SCT are diagnosed with a simple blood test (Centers for Disease
Control and Prevention, 2014). Screening is typically performed to identify newborns with SCD
so that appropriate care can be initiated as soon as possible. While screening for SCD, SCT
carriers are also identified. Because detection of SCT is not the primary purpose of the newborn
screening, some laboratories and hospitals may not convey the SCT finding directly to parents,
and therefore, parents of children with SCT may be unaware of their infant’s screening results
(Benenson, Porter, & Vitale, 2018).
A recent survey found that more than one third of screening follow-up programs have no
protocol in place that provides guidance for notification when infant tests are positive for SCT
(Patricia, Jason, Bradford, Philippa, & Howard, 2008). Lack of knowledge could potently put the
child at risk for complications and affect family planning later in life. Another study performed
on adult participants found that many participants were uncertain of their own trait status
(Harrison, Walcott, and Warner, 2017). A total of 5% of participants reported that they had SCT

(n = 14), and 42% indicated that they did not have SCT (n = 108). However, 14% (n = 36)
responded “I don’t know,” 36% (n = 94) responded “I don’t think I do,” and 2% (n = 6)
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responded “I think I do.” Together, the three groups who indicated uncertainty about their
personal trait status comprised 52% of the sample. The SCT Knowledge Questionnaire these
researchers used in Appendix B. This was the only SCT Knowledge Questionnaire that could be
identified.
ASCQ-ME
A comprehensive assessment system for SCD has been developed. The Adult Sickle Cell
Quality of Life Measurement Information System (ASCQ-ME), is a patient-reported outcome
measurement system that assesses the physical, social, and emotional impact of SCD. The
ASCQ-Me includes seven different measures. The measure is Emotional Impact, Pain Episode,
Pain impact, The Sickle Cell Disease Medical History Checklist, Sleep Impact, Social
Functioning Impact, and Stiffness impact. Although ASCQ-ME is used to measure patients with
SCD, it does not apply to patients with SCT. The ASCQ-ME represents a model that may be
used in the future for the developed for a comprehensive assessment system for SCT
Current Study Aims
The current study aims to survey self-reported health symptoms and knowledge of SCT
in young adults with an African heritage. The purpose is to expand a comprehensive assessment
system to measure SCT. Historically SCT was thought to be asymptomatic. However, current
research has suggested this may not be true. While young adults may have knowledge of SCD,
little is known about their awareness of SCT. Furthermore, no research on these topics have been
conducted in young adults with African heritage (Latino/Hispanic, Caribbean, multi-racial, etc.).
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Therefore, the present study aims to survey the health status, SCT knowledge, and SCT
awareness of young adults that this may affect.
Hypotheses
I.

African American participants will be more likely to know their SCT status than any
other group with African Heritage.

II.

African American participants will have higher SCT knowledge than any other group
with African Heritage.

III.

If enough participants with SCT respond to the survey, it is hypothesized that they
will report more physical symptoms than those who do not carry the trait.
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METHODS
Participants
Undergraduates enrolled in introductory psychology courses at a large university in the
southeastern United States were recruited to participate in ongoing research surveying selfreported health symptoms and knowledge of SCT in young adults with an African heritage. The
announcement for the study is listed in Appendix A. Participants received credit in the
Introductory psychology course which is a required part of the general education curriculum for
most majors at this university. Therefore, all college students and majors were well represented.
Eligibility criteria excluded students with no African or Hispanic heritage. Participants had to be
between the age of 18 and 25 years, and able to complete an online questionnaire in the English
language. This study was reviewed as exempt by the UCF Institutional Review Board (IRB) and
the letter stating this is presented in Appendix B.
Measures
Demographics Questionnaire. A 14-item background self-questionnaire to collect
demographic information was constructed for this study which includes age, major, gender,
racial or ethnic, health status, height, weight, classification in college and living status. This scale
is included in Appendix C.
SCT Knowledge Questionnaire. This questionnaire will test the knowledge of Sickle
Cell Trait. The participants were given 12 true or false questions about SCT. This scale was
constructed by Harrison, Walcott, and Warner (2017) and is included in Appendix D. There is no
currently available published reliability or validity data for this instrument. The internal
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consistency (Chronbach’s Alpha) of the SCT Knowledge Questionnaire items for the present
sample was .83.
Cohen Hoberman Physical Symptom Questionnaire (CHIPS). This questionnaire
measures of perceived severity and frequency of 33 common physical symptoms (Cohen &
Hoberman, 1983). This scale is included in Appendix E. The participants rate a series of physical
symptoms on how much a problem has bothered or distressed them during the past two weeks
including today. All 33-items are answered on a five-point scale from 0 (not been bothered by
the problem) to 4 (meaning the problem has been an extreme bother). Adequate reliability and
validity for the scale has been reported in Allen, Wetherell, and Smith (2017).
Validity Check Questions (Vcheck). Three questions were included to assess whether
participants responded in a random or careless manner. These questions were interspersed within
Demographics Questionnaire and the SCT Knowledge Questionnaire. Participants were
eliminated if they endorsed any of the items in the random or careless direction. The items are
listed in Appendix F.
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RESULTS
There were 88 total individuals who responded to the survey announcement and 28
participants were eliminated because they were from racial/ethnic groups without African
heritage. Six subjects exceeded the VCheck item criteria for random/careless responding were
also eliminated. The final study sample totaled 54 emerging adults between the age range of 18
and 25 (M=19.67, SD = 1.92) with 66.6% identifying as female. The survey took on average 17
minutes for participants to complete online. All respondents were single.
Participants were placed into three self-identified racial/ethnic groups, African American,
Hispanic, and Multi-Racial based on their responses on the Demographic Questionnaire. Thirtythree participants self-identified as African American, 12 self-identified as Hispanic/Latino, and
9 self-identified as Multi-Racial. There were no age or sex differences between these groups
when tested by ANOVA or Chi-Square. A greater percentage of the African American
participants (33.3%) were Freshman compared to the Hispanic/Latino and Multi-Racial groups
combined when tested by Chi-Square 8.478, df=3, p<.037. One of the participants in the Black
group reported having SCD, and 3 in the African American group reported having SCT. The
remainder of participants reported that they either did not have Sickle Cell Trait or did not know
their diagnostic status.
Hypothesis 1: Group Differences in Sickle Cell Carrier Status Awareness
Based on previous literature, this study hypothesized that the groups will differ on their
SCT carrier status awareness frequency with African American participants being significantly
more aware if they carry the gene or not. This was assessed with the following question from the
10

Demographics questionnaire: “Have you been diagnosed with Sickle Cell Trait?” Twelve percent
of the African American participants did not know their SCT carrier status as compared to 25%
and 67 percent of the Hispanic and Multi-Racial groups, respectively. This finding is presented
in Figure 1.

Figure 1: Sickle Cell Trait Status Awareness by Group

The 3 groups were tested with the Kruskal Wallis Test (a nonparametric test). There was
a statistically significant difference between the number of subjects aware of the Sickle Cell Trait
status between the different groups H(2) = 11.332, p = .003. Table 1 lists the Pairwise
comparisons of the three groups.
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Table 1
Pairwise Comparisons of Sickle Cell Status Awareness between the Groups
Sample 1-Sample 2

Test Statistic

Std. Error

Std. Test Statistic

Sig.

African American v.
Hispanic

-5.148

4.235

-1.216

.224

African American v.
Multi-Racial

-15.773

4.724

-3.339

.001

Hispanic v.
Multi-Racial

-10.625

.539

-1.918

.055

Review of Table 1 indicates the African American group were aware of their trait status
at significantly greater frequency than those from the Multi-Racial group. This difference
approached significance for the comparison between the African Americans and Hispanic
groups.
Hypothesis 2: Group Differences in Sickle Cell Trait Knowledge
Based on previous literature, this study hypothesized that the groups would differ on their
mean SCT Knowledge levels with African American participants having significantly greater
knowledge. The participants in the African American group scored 6.5 items correct, Hispanics
scored 5.2 items correct, and the Multi-Racial group scored 3.9. These findings are presented in
Figure 2.
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Figure 2: Sickle Cell Trait Knowledge Test Scores by Group

The SCT Knowledge scores were then compared with ANOVA. There was a statistically
significant main effect for group on the SCT Knowledge total score, F(2, 48) = 5.941, p < .01,
partial η2 = .198 and observed power of .858. Post hoc Tukey pairwise comparisons were then
conducted to evaluate how the groups differed from one another. The African American Group
demonstrated significantly higher scores on the SCT Knowledge total score than the MultiRacial group but not the Hispanic group. These results are summarized in Table 2.
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Table 2
Comparison of Groups on Sickle Cell Trait Knowledge
Mean (SD)

Variables

SCTKtot

Main Effect

African
American
(n=32)

Hispanic
(n=10)

MultiRacial
(n=9)

6.53
(2.37)

5.2
(1.69)

3.89
(1.45)

Post hoc tests

F

p

η2

5.941

< 0.01

.198

African
American
(v)
Hispanic

African
American
(v)
MultiRace

Hispanic
(v)
MultiRace

*

Note. Post-hoc comparisons were evaluated using Tukey’s HSD and are marked according to the degree of significant
difference. SCTKtot=Sickle Cell Trait Knowledge Total Score.
⁎ p < .05.

Hypothesis 3: Sickle Cell Trait Carriers Will Report More Physical Symptoms
Sickle Cell Trait Carriers were hypothesized to report more physical symptoms than
those who do not carry the trait. Unfortunately, only 3 participants reported knowing that they
were SCT carriers. This low number precluded any statistical comparisons of physical symptoms
between a SCT carrier group and non-carriers. For exploratory purposes, the individual
responses of the 3 individual SCT Carriers were compared to the group average of all other
participants (not including the one participant with SCD). Two of the 3 individual SCT carriers
were females, and they were 18, 22, and 23 years of age. Of the 33 physical symptoms listed on
the CHIPS, there was no individual symptom that all three of the SCT carrier individuals
reported. Furthermore, no symptom area for any of the SCT carriers appeared to be elevated
from the median response of non-carriers. The median response of non-carriers physical
symptoms was 0 for all responses except item 9. Headaches, which was 1. The responses of the
three Sickle Cell Carriers are summarized in Table 3 by item.
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Table 3
Individual Sickle Cell Trait Carriers’ Responses to the Cohen Hoberman Physical Symptom
Questionnaire (CHIPS).
SCT Carrier
CHIPS Items

1

2

3

1. Sleep Problems

2

0

3

2. Weight Change

0

4

0

3. Back Pain

0

4

3

4. Constipation

2

0

0

5. Dizziness

0

2

0

6. Diarrhea

1

2

0

7. Faintness

0

2

0

8. Constant Fatigue

0

0

0

9. Headache

0

1

2

10. Migraine Headache

2

0

1

11. Nausea and/or vomiting

0

0

0

12. Acid Stomach or Indigestion

0

0

0

13. Stomach Pain

1

2

0

14. Hot or Cold Spells

0

0

0

15. Hands Trembling

0

0

0

16. Heart Pounding or Racing

0

0

0

17. Poor Appetite

0

3

0

18. Shortness of Breath

0

0

3
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19. Numbness or Tingling

1

0

0

20. Felt Weak All Over

2

3

0

21. Pains in Heart or Chest

0

2

0

22. Feeling Low in Energy

2

0

0

23. Stuffy Head or Nose

0

0

3

24. Blurred Vision

1

2

1

25. Muscle Tension or Soreness

0

0

0

26. Muscle Cramps

0

0

0

27. Severe Aches and Pains

0

0

0

28. Acne

4

2

0

29. Bruises

0

0

0

30. Nosebleed

0

0

0

31. Pulled (Strained) Muscles

0

0

0

32. Pulled (Strained) Ligaments

0

0

0

33. Cold or Cough

0

0

0

Response Scale: 0-1=Not at all; 2=Several days; 3=More than half the days; 4=Nearly every day.
Median Response for Non-Carriers=0, Except for Item 9 which equaled 1.
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DISCUSSION
In the current study, young adults with an African heritage participated in a survey that
assessed awareness of the SCT carrier status, knowledge of SCT, and self-reported health
symptoms. The ultimate purpose of this survey was to expand a comprehensive assessment
system to measure SCT. As stated in the literature review, being knowledgeable of sickle trait
status is important for individuals with African Heritage. This is particularly relevant to family
planning and there is emerging evidence that sickle cell trait is not asymptomatic. But, to become
knowledgeable of one’s sickle cell trait status, genetic testing is required. Testing for SCT and
SCD is routinely administered to African Americans in the United States. However, formal
feedback of SCT status is not consistent. Furthermore, it is not clear the extent to which
individuals with African heritage (many Hispanics and Multi-Racial) are routinely tested and
provided feedback.
The first hypothesis was that African American participants will be more likely to know
their status than any other group with African Heritage. As seen in Table 1, this first hypothesis
was partially supported. That is, the African American group demonstrated significantly more
awareness of their Sickle Cell Trait status than those from the Multi-Racial group. The difference
between the African American and Hispanic groups was not significant, but the difference
between the Hispanic and Multi-Racial groups approached significance (p.=.055), suggesting
that Multi-Racial individuals were the least informed of any group.
The second hypothesis predicted African American participants would have higher SCT
knowledge than the other two groups with African Heritage. As seen in Table 2, the findings
17

partially supported the hypothesis. The results showed African American demonstrated
significantly higher scores on the SCT Knowledge Questionnaire than the Multi-Racial group,
but not the Hispanic group. This demonstrates the lack of SCT knowledge in Multi-Racial
individuals when compared to African Americans. Which proves individuals are unaware of the
risks and complications of SCT. This can put an individual life at risk and affect family planning.
Finally, the third hypothesis stated if enough participants with SCT responded to the
survey, they would report more physical symptoms than those who do not carry the trait.
Unfortunately, an insufficient number of participants with SCT responded to the survey, and the
third hypothesis could not be statistically analyzed. However, three participants did report that
they had SCT. Visual inspection of Table 3 did not reveal any symptom pattern that the SCT
carriers reported differently than the rest of the participants combined. That is, none of the
symptoms of these three individuals appeared to be elevated from median response of NonCarriers as a group.
The primary limitation of this study was the small sample size. Data was collected from
the undergraduate subject pool for approximately two months. Even though there were up to
1000 students enrolled in eligible classes during this interval, the number of students with
African American heritage was much less. In addition, college students cannot be viewed as
representative of the population. Therefore, dues to the small sample size and the sample biases
(higher SES and higher education), this study should be considered preliminary to larger efforts.
Indeed, the sample collection is continuing for the next several semesters and the hope is that the
findings will be reported in scientific journals.
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Another primary limitation in this study was the difficulty in classifying racial and ethnic
backgrounds. When it came to classifying Hispanic/Latino individuals, some participants selfidentified as Hispanic/Latino, but then reported black grandparents. The approach taken here was
to place individuals into the group they self-identified. Conversely, other participants selfidentified as Multi-Racial reported only one black grandparent. Future studies may wish to
modify the demographic section to add even more specificity in the reporting of racial and ethnic
background. Another limitation discovered was having a category of Multi-Racial did not
provide sufficient detail for analysis of African heritage because a general category of MultiRace could include individuals with Asian, Native American, and Pacific Islander background. It
is very difficult to understand the importance of sickle cell testing across races with so much
variability in the groups. The simplest solution in the future may be to test all newborns for SCT
status irrespective of the parents reported racial identity and then to have a clear mechanism to
report these results so they are retrievable by the individual from their medical records.
In conclusion Sickle Cell Trait testing should be a routine part of post-natal care for all
individuals without regard to race given the increasing complexity of racial heritage. While the
concept of racial identify is essential to study socioeconomic and psychosocial variables, it is
does not have the same level of utility when studying biological/disease variables such as SCT
and SCD. The complexity of race is becoming too varied of a concept to guide medical
treatment in the future.

19

APPENDIX A: STUDY ANNOUNCEMENT
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EXPLANATION OF RESEARCH

Title of Project: Self-Reported Health Status and Sickle Cell Trait Knowledge in Young Adults
with an African Heritage at a Large University in the Southeast
Principal Investigator: Jeffrey E. Cassisi, Ph.D., Professor
Other Investigators: Vinkrya Ellison HIM student
Faculty Supervisor: Jeffrey E. Cassisi, Ph.D., Professor
You are being invited to take part in a research study. Whether you take part is up to you.
Much is known about the effects of Sickle Cell Disease, a genetic condition that mostly effects
people with an African heritage. Sickle Cell Disease is distinguished from a condition known as
Sickle Cell Trait, Sickle Cell Trait describes a condition when a person carries the gene for
Sickle Cell Disease, but doesn't have it fully expressed. Less is known about the effects of Sickle
Cell Trait. The current study aims to survey self-reported health symptoms and knowledge of
Sickle Cell Trait in young adults with an African heritage. The purpose is to expand a
comprehensive assessment system to measure Sickle Cell Trait. Furthermore, few studies have
been conducted on Sickle Cell Trait in young adults with African heritage (multirace,
Latino/Hispanic Caribbean, etc.). Therefore, the present study aims to survey the health status,
Sickle Cell Trait knowledge, and Sickle Cell Trait awareness of young adults who are at risk for
this condition.
You will be presented with an online survey which will ask a series of questions measuring
Sickle Cell Trait knowledge and Self-Reported Health Symptoms. You may take the survey on
any computer you prefer. Please be assured that your responses will be kept in encrypted
computer files in the Health Psychology Laboratory (PSY 205) and no identifying information
will be collected. This online survey should take less than 1- hour to complete.
Your participation in this study is voluntary. You are free to withdraw your consent and
discontinue participation in this study at any time without prejudice or penalty. Your decision to
participate or not participate in this study will in no way affect your relationship with UCF,
including continued enrollment, grades, employment or your relationship with the individuals
who may have an interest in this study.
There is no foreseeable risk or discomfort to you by participating in this research. However, if
participation in this research has raised any concern regarding your health, medical services at
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the UCF Student Health Center are available to you as well. Please visit http://shs.sdes.ucf.edu/
for more information.
You must be 18 years of age or older and at risk for Sickle Cell Disease or Sickle Cell Trait to
take part in this research study. This includes young adults with African heritage (multirace,
Latino/Hispanic, Caribbean, etc.).
Individuals of American Indian or other Native American, Asian or Pacific Islander, Caucasian
(other than Hispanic) individuals are not eligible to participate since Sickle Cell Disease or
Sickle Cell Trait does not generally affect individuals of those race/ethnicities.
Study contact for questions about the study or to report a problem: If you have questions,
concerns, or complaints, please contact:
•
•

Vinkrya Ellison, HIM student, Department of Psychology by email at Kay25@Knight.ucf.edu
Dr. Jeffrey E. Cassisi, Faculty Supervisor, Department of Psychology by email at
Jeffrey.Cassisi@ucf.edu

IRB contact about your rights in this study or to report a complaint: If you have questions
about your rights as a research participant, or have concerns about the conduct of this study,
please contact Institutional Review Board (IRB), University of Central Florida, Office of
Research, 12201 Research Parkway, Suite 501, Orlando, FL 32826-3246 or by telephone at
(407) 823-2901, or email irb@ucf.edu.
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APPENDIX C: DEMOGRAPHICS QUESTIONNAIRE
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Demographics Questionnaire
The following questions will ask you about your background. Please read each question carefully
and then select the answer that best describe you.
D1 How old are you? (in years)
________________________________________________________________
D2 What is your sex?
o

Male (1)

o

Female (2)

o

other (3) ________________________________________________

D3 What is your racial or ethnic identification?
o

American Indian or other Native American (1)

o

Asian or Pacific Islander (2)

o

Black or African American (3)

o

Caucasian (other than Hispanic) (4)

o

Mexican-American (5)

o

Puerto Rican (6)

o

Other Hispanic (7) ________________________________________________

o

Other (8) ________________________________________________

D4 Which of your biological parents or biological grandparents are black? (Check all that apply)
▢

Mother (1)

▢

Father (2)

▢

Maternal Grandmother (Mom's mother) (3)

▢

Maternal Grandfather (Mom's father) (4)

▢

Paternal Grandmother (Dad's mother) (5)

▢

Paternal Grandfather (Dad's father) (6)
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D5 What is your marital status?
o

Married (13)

o

Widowed (14)

o

Divorced (15)

o

Separated (16)

o

Never married (17)

D6 What is your classification in college?
o

Freshman/First Year (20)

o

Sophomore (21)

o

Junior (22)

o

Senior (23)

o

Graduate Student (24)

o

Unclassified (26)

D7 How tall are you without shoes?
D8 How much do you weigh, in pounds (lbs)?
D9 Are you a smoker? (this includes e-cigarettes & vape pens)
o

Yes (1)

o

No (2)

o

Ex-Smoker (3)

D10 Have you been diagnosed with Sickle Cell Trait?
o

Yes (1)

o

No (2)

o

I do not know (3)

D11 Have you been diagnosed with Sickle Cell Disease?
o

Yes (1)

o

No (2)
29

o

I do not know (3)
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The following questions will ask you about your knowledge of Sickle Cell Trait. Please read
each question carefully and then select true or false based on what you know about Sickle Cell
Trait.SCTKQ1 Sickle Cell Trait can turn into Sickle Cell Disease
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ2 If a person has Sickle Cell Trait, it can be passed on to his or her children
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ3 Sickle Cell Trait often causes pain crises
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ4 People with Sickle Cell Trait have inherited a gene for sickle hemoglobin from one
parent but not the other
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ5 People with Sickle Cell Trait who are athletes such as football players may be at risk
of sudden death
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ6 Most people with Sickle Cell Trait live long, healthy lives
o

True (1)

o

False (2)

o

I do not know (3)
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SCTKQ7 If a person has Sickle Cell Trait, all his or her children will have Sickle Cell Trait
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ8 Sickle Cell Trait is only passed down through the mother
o

True (1)

o

False (2)

o

I do not know (5)

SCTKQ9 People from all racial/ethnic backgrounds can be affected by Sickle Cell Trait
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ10 All states in the United States screen newborns babies for Sickle Cell Trait as well as
other conditions
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ11 Sickle Cell Trait causes many medical problems
o

True (1)

o

False (2)

o

I do not know (3)

SCTKQ12 Sickle Cell Trait results many more deaths each year than Sickle Cell Disease
o

True (1)

o

False (2)

o

I do not know (3)
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Mark the number for each statement that best describes HOW MUCH THAT PROBLEM HAS
BOTHERED OR DISTRESSED YOU DURING THAT PAST TWO WEEKS INCLUDING
TODAY. Mark only one number for each item. At one extreme, 0 means that you have not been
bothered by the problem. At the other extreme, 4 means that the problem has been an extreme
bother. HOW MUCH WERE YOU BOTHERED BY:
1.

Sleep problems (can't fall asleep, wake up in middle of night or early in morning)

2.

Weight change (gain or loss of 5 libs. or more)

3.

Back pain

4.

Constipation

5.

Dizziness

6.

Diarrhea

7.

Faintness

8.

Constant fatigue

9.

Headache

10.

Migraine headache

11.

Nausea and/or vomiting

12.

Acid stomach or indigestion

13.

Stomach pain (e.g., cramps)

14.

Hot or cold spells

15.

Hands trembling

16.

Heart pounding or racing

17.

Poor appetite

18.

Shortness of breath when not exercising or working hard

19.

Numbness or tingling in parts of your body

20.

Felt weak all over

21.

Pains in heart or chest

22.

Feeling low in energy

23.

Stuffy head or nose
36

24.

Blurred vision

25.

Muscle tension or soreness

26.

Muscle cramps

27.

Severe aches and pains

28.

Acne

29.

Bruises

30.

Nosebleed

31.

Pulled (strained) muscles

32.

Pulled (strained) ligaments

33.

Cold or cough
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WITHIN THE STANDARD DEMOGRAPHICS SECTION
V01 Are you between the age of 18 and 25?
o Yes (1)
o No (0)
V02 For this item, please select No
o Yes (0)
o No (1)
WITHIN THE SCT KNOWLEDGE QUESTIONNAIRE SECTION
V03 For this question, please select the "False" option
o True (0)
o False (1)

39

REFERENCES
Allen, S. F., Wetherell, M. A., & Smith, M. A. (2017). The Cohen-Hoberman inventory
of physical symptoms: Factor structure, and preliminary tests of reliability and validity in the
general population. Psychology & Health, 32(5), 567–587.
https://doi.org/10.1080/08870446.2017.1290237
American Society of Hematology. (2018, January 8). Retrieved from
http://www.hematology.org/Patients/Anemia/Sickle-Cell.aspx
Benenson, I., Porter, S., & Vitale, T. (2018). Sickle Cell Trait: What Every Nurse
Practitioner Should Know. Journal for Nurse Practitioners, 14(9), 663–670.
https://doi.org/10.1016/j.nurpra.2018.07.020
Centers for Disease Control and Prevention. (2014). National diabetes statistics report:
Estimates of diabetes and its burden in the United States. Atlanta, GA: US Department of Health
and Human Services. Retrieved from https://www.cdc.gov/diabetes/pubs/statsreport14/nationaldiabetes-report-web.pdf
Harrison, S. E., Walcott, C. M., & Warner, T. D. (2017). Knowledge and Awareness of
Sickle Cell Trait Among Young African American Adults. Western Journal Of Nursing
Research, 39(9), 1222-1239. https://doi.org/10.1177/0193945916665089
Home. (n.d.). Retrieved from http://www.healthmeasures.net/explore-measurementsystems/ascq-me/intro-to-ascq-me/list-of-measures
McInnes, B. K., 3rd. (1980). The management of hematuria associated with sickle
hemoglobinopathies. The Journal of Urology, 124(2), 171–174. Retrieved from

40

https://searchebscohostcom.ezproxy.net.ucf.edu/login.aspx?direct=true&db=cmedm&AN=74012
25&site=eds-live&scope=site
Murray, M. J., & Evans, P. (1996). Sudden exertional death in a soldier with sickle cell
trait. Military Medicine, 161(5), 303–305. Retrieved from https://search-ebscohostcom.ezproxy.net.ucf.edu/login.aspx?direct=true&db=cmedm&AN=8855065&site=ehostlive&scope=site
Patricia L., K., Jason C., W., Bradford L., T., Philippa G., S., & Howard, B. (2008).
Communication of positive newborn screening results for sickle cell disease and sickle cell trait:
Variation across states. American Journal of Medical Genetics - C, (1), 15. https://doiorg.ezproxy.net.ucf.edu/10.1002/ajmg.c.30160
National Institutes of Health. (2012). Sickle cell disease - Genetics Home Reference U.S. National Library of Medicine. https://ghr.nlm.nih.gov/condition/sickle-cell-disease
Singer, D. E., Chen, L., Shao, S., Goldsmith, J., Byrne, C., & Niebuhr, D. W. (2018). The
Association Between Sickle Cell Trait in U.S. Service Members with Deployment, Length of
Service, and Mortality, 1992-2012. Military Medicine, 183(3–4), e213–e218. https://doiorg.ezproxy.net.ucf.edu/10.1093/milmed/usx037
Tsaras, G., Owusu-Ansah, A., Boateng, F. O., & Amoateng-Adjepong, Y. (2009).
Complications Associated with Sickle Cell Trait: A Brief Narrative Review. American Journal of
Medicine, 122(6), 507512. https://doiorg.ezproxy.net.ucf.edu/10.1016/j.amjmed.2008.12.020
Ustün, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J.,
Saxena, S., von Korff, M., & Pull, C. (2010). Developing the World Health Organization
41

Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–
823. https://doi.org/10.2471/BLT.09.067231
Watanabe, I. C., Billis, A., Guimarães, M. S., Alvarenga, M., de Matos, A. C.,
Cardinalli, I. A., … Suzigan, S.

(2007). Renal medullary carcinoma: report of seven cases from

Brazil. Modern Pathology: An Official Journal of the United States and Canadian Academy of
Pathology, 20(9), 914–920. Retrieved from https://search-ebscohostcom.ezproxy.net.ucf.edu/login.aspx?direct=true&db=cmedm&AN=17643096&site=edslive&scope=site
World Health Organization. (2010). Sickle-cell disease: A strategy for the WHO African
region (WHO Publication No. AFR/RC60/8). Malabo, Equatorial Guinea: Regional Office for
Africa, World Health Organization.
Yanamandra, U., Das, R., Malhotra, P., & Varma, S. (2018). A Case of Autosplenectomy
in Sickle Cell Trait Following an Exposure to High Altitude. Wilderness & Environmental
Medicine, 29(1), 85–89. https://doi-org.ezproxy.net.ucf.edu/10.1016/j.wem.2017.08.021

Title

42

